455 results on '"Nolte, Florian"'
Search Results
2. Stroke-based Rendering: From Heuristics to Deep Learning
3. Inhibition of lysyl oxidases synergizes with 5-azacytidine to restore erythropoiesis in myelodysplastic and myeloid malignancies
4. Finanzwirtschaft im Umbruch – Auswirkungen auf die Berufsausbildung am Beispiel des Ausbildungsberufes Bankkaufmann/Bankkauffrau
5. Note on crystallization for alternating particle chains
6. Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
7. Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes
8. Magnetic domains in thin ferromagnetic films with strong perpendicular anisotropy
9. Renal Extramedullary Hematopoiesis in Mast Cell Leukemia with Bone Marrow Fibrosis
10. Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)
11. Influence of the Insertion Site on Central Venous Catheter-Related Complications in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
12. Note on Crystallization for Alternating Particle Chains
13. Bone marrow derived stromal cells from myelodysplastic syndromes are altered but not clonally mutated in vivo
14. Diagnostik und Management des myelodysplastischen Syndroms
15. 3. Krankheitsspezifische Therapieoptionen bei myeloischen Neoplasien
16. Safety and efficacy of the CD95-ligand inhibitor asunercept in transfusion-dependent patients with low and intermediate risk MDS
17. Magnetic Domains in Thin Ferromagnetic Films with Strong Perpendicular Anisotropy
18. Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens
19. Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure
20. Stroke-based Rendering: From Heuristics to Deep Learning
21. Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide
22. A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia
23. Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome – Emphasis on optimized dosing schedules and new formulations
24. Inhibition of Lysyl Oxidases Synergizes with 5-Azacytidine to Restore Erythropoiesis in Myeloid Neoplasms
25. Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial
26. Molecular Changes in Myelodysplastic Syndrome
27. In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival
28. Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA
29. Concomitant MDS with isolated 5q deletion and MGUS: case report and review of molecular aspects
30. The insertion site is the main risk factor for central venous catheter‐related complications in patients with hematologic malignancies
31. Mesenchymal Stromal Cells (MSCs) from Myelodysplastic Syndromes (MDS) Are Not Clonally Mutated I n Vivo
32. Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study)
33. Assessment of acute intestinal graft versus host disease by abdominal magnetic resonance imaging at 3 Tesla
34. Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability
35. Management of elderly patients with acute promyelocytic leukemia: progress and problems
36. High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia
37. Preclinical evaluation of eltrombopag in a PDX model of myelodysplastic syndromes
38. Characteristics of MDS patients seen at private practices differ significantly from those treated at university hospitals in Germany
39. Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study
40. Frequent pathway mutations of splicing machinery in myelodysplasia
41. Takotsubo Cardiomyopathy after Systemic Consolidation Therapy with High-Dose Intravenous Cytarabine in a Patient with Acute Myeloid Leukemia
42. Myelodysplastic syndromes: molecular pathogenesis and genomic changes
43. Monitoring of Virtual and Hybrid Test Benches in the Cloud
44. High erythroferrone expression in CD71+ erythroid progenitors predicts superior survival in myelodysplastic syndromes
45. Clinical Response to the CD95-Ligand Inhibitor Asunercept Is Defined by a Pro-Inflammatory Serum Cytokine Profile
46. Skewed X-inactivation patterns in ageing healthy and myelodysplastic haematopoiesis determined by a pyrosequencing based transcriptional clonality assay
47. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis
48. Comparative analysis of clonal hematopoiesis of multipotent stem cells in healthy elderly in blood and bone marrow
49. Replication stress signaling is a therapeutic target in myelodysplastic syndromes with splicing factor mutations
50. MDS-141: The Prognostic Impact of Cytogenetic Scores in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Venetoclax and Azacitidine in a Phase 1 Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.